Arnica Tincture Cures Cutaneous Leishmaniasis in Golden Hamsters

Molecules. 2018 Jan 12;23(1):150. doi: 10.3390/molecules23010150.

Abstract

In search for potential therapeutic alternatives to existing treatments for cutaneous Leishmaniasis, we have investigated the effect of Arnica tincture Ph. Eur. (a 70% hydroethanolic tincture prepared from flowerheads of Arnica montana L.) on the lesions caused by infection with Leishmania braziliensis in a model with golden hamsters. The animals were treated topically with a daily single dose of the preparation for 28 days. Subsequently, the healing process was monitored by recording the lesion size in intervals of 15 days up to day 90. As a result, Arnica tincture fully cured three out of five hamsters while one animal showed an improvement and another one suffered from a relapse. This result was slightly better than that obtained with the positive control, meglumine antimonate, which cured two of five hamsters while the other three showed a relapse after 90 days. This result encourages us to further investigate the potential of Arnica tincture in the treatment of cutaneous Leishmaniasis.

Keywords: Arnica montana L.; cutaneous Leishmaniasis; neglected tropical disease.

MeSH terms

  • Animals
  • Antiprotozoal Agents / chemistry*
  • Antiprotozoal Agents / isolation & purification
  • Antiprotozoal Agents / therapeutic use
  • Arnica / chemistry*
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Female
  • Lactones / chemistry*
  • Lactones / isolation & purification
  • Lactones / therapeutic use
  • Leishmania braziliensis / drug effects
  • Leishmaniasis, Cutaneous / drug therapy*
  • Male
  • Meglumine Antimoniate / pharmacology
  • Meglumine Antimoniate / therapeutic use
  • Mesocricetus
  • Plant Extracts / chemistry*
  • Plant Extracts / therapeutic use
  • Structure-Activity Relationship

Substances

  • Antiprotozoal Agents
  • Lactones
  • Plant Extracts
  • Meglumine Antimoniate